We conclude that HER2-positive and TNBC breast cancer patients with a selenium blood level above 107.19 μg/L before starting NAC have a higher pCR rate than patients with selenium levels below 94.29 μg/L. This evidence concerns the gene ERBB2 and breast carcinoma.